ADMA Biologics
ADMA
ADMA
179 hedge funds and large institutions have $611M invested in ADMA Biologics in 2023 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 58 increasing their positions, 62 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.03% more ownership
Funds ownership: 74.42% → 74.46% (+0.03%)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
6% less repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 62
Holders
179
Holding in Top 10
5
Calls
$2.39M
Puts
$994K
Top Buyers
| 1 | +$12.7M | |
| 2 | +$10.8M | |
| 3 | +$4.65M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$4.51M |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$4.18M |
Top Sellers
| 1 | -$9.13M | |
| 2 | -$9.09M | |
| 3 | -$6.4M | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$5.83M |
| 5 |
VCIM
Velan Capital Investment Management
Alpharetta,
Georgia
|
-$4.7M |